Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...

Monte Rosa Therapeutics Inc., a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, has agreed to collaborate with Novartis to develop novel degraders ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Vacuoles, E1 enzyme, X ...

Panelists discuss how atopic dermatitis involves complex inflammatory and neuronal pathways, with IL-4, IL-13, and IL-31 cytokines driving Th2-mediated inflammation that varies across different racial ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Idiopathic inflammatory ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...

Pain among patients with idiopathic inflammatory myopathies was associated with worse physical function, increased fatigue, and reduced quality of life. Pain is highly prevalent among patients with ...